Completed Nivolumab Consolidation in Older (≥ 65) Patients With Primary CNS Lymphoma NCT04022980 Conditions Brain and Nervous System, Eye and Orbit, Hemic and Lymphatic Diseases, +11 more Locations Dana Farber Cancer Institute — Brookline, Massachusetts, United States UNC Hospitals, The University of North Carolina at Chapel Hill — Chapel Hill, North Carolina, United States Levine Cancer Institute — Charlotte, North Carolina, United States The University of Texas - MD Anderson Cancer Center — Houston, Texas, United States View Trial Details
